Literature DB >> 2208753

Insulin resistance, energy balance and sympathetic nervous system activity.

L Landsberg1.   

Abstract

Insulin resistance and hyperinsulinemia are commonly associated with hypertension in the obese. The nature of this association is obscure. An hypothesis is developed that attributes obesity-related hypertension to sympathetic stimulation. The relationship between insulin and the sympathetic nervous system (SNS) has its origins in the mediation of dietary thermogenesis. Fasting suppresses while carbohydrate and fat feeding stimulate sympathetic activity. Insulin-mediated glucose metabolism within critical central neurons links dietary intake and central sympathetic outflow. The sympathetic nervous system, in turn, contributes to changes in metabolic rate that accompany alterations in dietary intake. It is hypothesized that insulin resistance is a mechanism recruited in the obese to limit further weight gain and stabilize body mass. Insulin-mediated sympathetic stimulation is one mechanism that may restore energy balance in the obese since the obese are not resistant to the stimulatory effect of insulin on the SNS. Sympathetically mediated stimulation of the heart, vasculature and kidney contributes, in genetically predisposed individuals, to the development of hypertension. Viewed in this light, obesity-related hypertension is the unfortunate by-product of an adaptive mechanism (insulin resistance) recruited to restore energy balance in the obese. Possible implications of this formulation are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2208753     DOI: 10.3109/10641969009073502

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  13 in total

Review 1.  Obesity and adipokines: effects on sympathetic overactivity.

Authors:  Michael M Smith; Christopher T Minson
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

Review 2.  Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure.

Authors:  André J Scheen
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

3.  Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain.

Authors:  M Spraul; E Ravussin; A M Fontvieille; R Rising; D E Larson; E A Anderson
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

4.  Sympathetic responses to repetitive trans-spinal magnetic stimulation.

Authors:  Roger J Paxton; Matthew P Malcolm; Sean A Newsom; Jennifer C Richards; Grant M Rynn; Christopher Bell
Journal:  Clin Auton Res       Date:  2010-11-27       Impact factor: 4.435

5.  Sympathetic inhibition attenuates hypoxia induced insulin resistance in healthy adult humans.

Authors:  Garrett L Peltonen; Rebecca L Scalzo; Melani M Schweder; Dennis G Larson; Gary J Luckasen; David Irwin; Karyn L Hamilton; Thies Schroeder; Christopher Bell
Journal:  J Physiol       Date:  2012-04-10       Impact factor: 5.182

Review 6.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06

7.  Correlation Between Plasma Catecholamines, Weight, and Diabetes in Pheochromocytoma and Paraganglioma.

Authors:  Lauren N Krumeich; Andrew J Cucchiara; Katherine L Nathanson; Rachel R Kelz; Lauren Fishbein; Douglas L Fraker; Robert E Roses; Debbie L Cohen; Heather Wachtel
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

8.  Elevated resting heart rate is associated with the metabolic syndrome.

Authors:  Ori Rogowski; Arie Steinvil; Shlomo Berliner; Michael Cohen; Nili Saar; Orit Kliuk Ben-Bassat; Itzhak Shapira
Journal:  Cardiovasc Diabetol       Date:  2009-10-14       Impact factor: 9.951

9.  Sympathoexcitation associated with Renin-Angiotensin system in metabolic syndrome.

Authors:  Takuya Kishi; Yoshitaka Hirooka
Journal:  Int J Hypertens       Date:  2013-02-13       Impact factor: 2.420

10.  Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients.

Authors:  Marcel Mazur; Agata Furgała; Konrad Jabłoński; Tomasz Mach; Piotr Thor
Journal:  Med Sci Monit       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.